During the past decade, Sez. di medicina Interna Oncologia ed Ematologia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sez. di medicina Interna Oncologia ed Ematologia" #1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sez. di medicina Interna Oncologia ed Ematologia" are "Indolent B-Cell Lymphomas" (1 trials), "Leukemia" (1 trials), "Lymphoblastic Leukemia, Acute" (1 trials), "Malignant Melanoma" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "Sez. di medicina Interna Oncologia ed Ematologia" in a lesser frequency.

Most popular intervention types in "Sez. di medicina Interna Oncologia ed Ematologia" are "Drug" (6 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Any treatment, watch and wait policy included" (1 trials), "Atezolizumab" (1 trials), "Bendamustine" (1 trials), "Bevacizumab" (1 trials) and "Cyclophosphamide 750 mg/m^2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sez. di medicina Interna Oncologia ed Ematologia" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Sez. di medicina Interna Oncologia ed Ematologia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sez. di medicina Interna Oncologia ed Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sez. di medicina Interna Oncologia ed Ematologia, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".